Alexandra Cocores

Exploring the Dynamic Relationship Between Migraine and Functional Neurological Disorders: A Narrative Review

Tiffany Eatz, Jason Margolesky, Alexandra Cocores

PURPOSE OF REVIEW: Headache and functional neurologic disorders (FND) are the most diagnosed neurologic disorders, yet their relationship has not been comprehensively detailed. RECENT FINDINGS : Understandings of migraine and FND have each progressed tremendously. Headache may be the most common neurologic …

us (code pays fourni par la source)

Virtual issue: Education in headache medicine: Insights and advancements from 2023 to 2024

Alexandra Cocores, Anna Pace

Anna Pace has received honoraria for speaking from the American Headache Society and American Academy of Neurology.

us (code pays fourni par la source)

Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report

Olivia Burke, Alexandra Cocores, Jacob Beer, Jonette Keri

Calcitonin gene-related peptide (CGRP) is a neuropeptide involved in neurogenic inflammation and vasodilation, playing a key role in the pathophysiology of both migraines and inflammatory skin conditions, including acne and rosacea. This case report presents a 30-year-old woman with a long-standing history …

Connecting the Dots: Correlation Between Headache and Psychosomatic Factors in Functional Movement Disorders Interdisciplinary Clinic Patients (P10-5.020)

Tiffany Eatz, Alexandra Cocores, Jason Margolesky

We aim to explore the relationship between headache and psychosomatic factors in patients with functional movement disorders (FMD) presenting to interdisciplinary specialty clinic (IDC) via investigation of their headache presence/characteristics, comorbid conditions, and demographic attributes.

us (code pays fourni par la source)

Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications

Alexandra Cocores, Liza Smirnoff, Guy Greco, Teshamae Monteith

PURPOSE OF REVIEW: Neuromodulation techniques currently available for headache management are reviewed in this article, with a focus on recent advances in non-invasive devices for migraine and trigeminal autonomic cephalalgias. RECENT FINDINGS: The currently available FDA-cleared non-invasive devices for migraine include transcutaneous …

us (code pays fourni par la source)

Migraine, Vascular Disorders and Complications

Alexandra Cocores, Teshamae Monteith

us (code pays fourni par la source)

International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine

Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, Messoud Ashina et autres

CA extern

gb, it, de, dk, us, kr, Ghana, tr, es, Égypte, jp, au, tw, ar, br, nl, ir, be, cn (code pays fourni par la source)

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, Messoud Ashina et autres

BACKGROUND: In an effort to improve migraine management around the world, the International Headache Society (IHS) has here developed a list of practical recommendations for the acute pharmacological treatment of migraine. The recommendations are categorized into optimal and essential, in order to …

gb, it, de, dk, us, kr, Ghana, tr, es, Égypte, jp, au, ar, tw, br, nl, ir, be, cn (code pays fourni par la source)

Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review

Miguel Fernández Ruiz, Alexandra Cocores, Antonellá Tosti, Peter J. Goadsby et autres

BACKGROUND: Alopecia is associated with erenumab post-marketing, but no cases have been described. METHODS: We describe two patients that reported temporary hair loss and review the FDA Adverse Event Reporting System (FAERS). RESULTS: The first patient experienced alopecia within three months of …

us, gb (code pays fourni par la source)

Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System

Alexandra Cocores, Peter J. Goadsby, Teshamae Monteith

OBJECTIVE: To assess the characteristics and associated disability of headache as an adverse event following vaccination. BACKGROUND: According to clinical trials and post-licensure surveillance, headache is a common symptom of vaccines, yet systematic investigations of post-licensure reports of this adverse event are …

us, gb (code pays fourni par la source)

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting

Kimberly Garces, Alexandra Cocores, Peter J. Goadsby, Teshamae Monteith

us, gb (code pays fourni par la source)

Headache as an Early Symptom and Post-Acute Sequela of COVID19 in Hospitalized COVID19 Survivors (S4.008)

Teshamae Monteith, Alexandra Cocores, Mejgan Mukhtarzada, Natalia Rincon et autres

To evaluate acute and persistent headache in hospitalized COVID19 survivors.

us (code pays fourni par la source)